Holdings Channel
EntityShares/Amount
Change
Position Value
Change
ARGX +35,000+$13,315
SLNO +309,950+$12,475
CBAY +489,938+$11,572
OLMA +659,035+$9,246
ALPN +357,271+$6,810
AVDL +347,036+$4,900
HARP +428,400+$4,871
EntityShares/Amount
Change
Position Value
Change
CYTK -223,382-$6,581
ARDX -881,356-$3,596
MRTX -70,283-$3,062
BDTX -634,191-$1,820
EntityShares/Amount
Change
Position Value
Change
GERN +750,000+$1,560
PMN +534,759+$174
JSPR +515,091+$686
AMAM +104,294+$2,255
MRUS +53,539+$2,340
AMLX +3,083-$934
CNTX UNCH-$276
MDVL UNCH-$178
AXSM -9,738+$298
XENE -25,000+$2,026
EntityShares/Amount
Change
Position Value
Change
PRAX -985,946-$237
CMPX -80,000-$500
MLTX -39,626-$1,772
ITCI -33,652+$1,007
APLS -31,805+$2,063
Size ($ in 1000's)
At 12/31/2023: $141,840
At 09/30/2023: $85,198

Combined Holding Report Includes:
Ally Bridge Group NY LLC
Fan Yu

Ally Bridge Group NY LLC holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Ally Bridge Group NY LLC 13F filings. Link to 13F filings: SEC filings

All Stocks Held By Ally Bridge Group NY LLC
As of  12/31/2023, we find all stocks held by Ally Bridge Group NY LLC to be as follows, presented in the table below with each row detailing each Ally Bridge Group NY LLC position, ordered by largest to smallest position size. The all-stocks-held-by-Ally Bridge Group NY LLC table shows the entity held in the first column (click any entity to explore other funds holding positions), the share amount held, the share count change between the last two reporting periods, and finally the position size for all stocks held by Ally Bridge Group NY LLC as of the latest filing.

   EntityAmountChange
 09/30/2023 to 12/31/2023
Position Size
($ in 1000's)
ARGENX SE ADR 35,000 +35,000 $13,315
     ARGX35,000+35,000$13,315
SOLENO THERAPEUTICS INC 309,950 +309,950 $12,475
     SLNO309,950+309,950$12,475
CYMABAY THERAPEUTICS INC 489,938 +489,938 $11,572
     CBAY489,938+489,938$11,572
XENON PHARMACEUTICALS INC 241,961 -25,000 $11,145
     XENE241,961-25,000$11,145
INTRA CELLULAR THERAPIES INC 141,348 -33,652 $10,123
     ITCI141,348-33,652$10,123
OLEMA PHARMACEUTICALS INC 659,035 +659,035 $9,246
     OLMA659,035+659,035$9,246
APELLIS PHARMACEUTICALS INC 150,000 -31,805 $8,979
     APLS150,000-31,805$8,979
MOONLAKE IMMUNOTHERAPEUTICS 143,479 -39,626 $8,665
     MLTX143,479-39,626$8,665
AXSOME THERAPEUTICS INC 100,862 -9,738 $8,028
     AXSM100,862-9,738$8,028
MERUS NV 274,923 +53,539 $7,560
     MRUS274,923+53,539$7,560
ALPINE IMMUNE SCIENCES INC 357,271 +357,271 $6,810
     ALPN357,271+357,271$6,810
GERON CORP 2,971,639 +750,000 $6,270
     GERN2,971,639+750,000$6,270
AMBRX BIOPHARMA INC 385,383 +104,294 $5,488
     AMAM385,383+104,294$5,488
AVADEL PHARMACEUTICALS ADR 347,036 +347,036 $4,900
     AVDL347,036+347,036$4,900
HARPOON THERAPEUTICS INC 428,400 +428,400 $4,871
     HARP428,400+428,400$4,871
AMYLYX PHARMACEUTICALS INC 275,773 +3,083 $4,059
     AMLX275,773+3,083$4,059
JASPER THERAPEUTICS INC 3,659,255 +515,091 $2,887
     JSPR3,659,255+515,091$2,887
PRAXIS PRECISION MEDICINES I 70,424 -985,946 $1,569
     PRAX70,424-985,946$1,569
COMPASS THERAPEUTICS INC 834,630 -80,000 $1,302
     CMPX834,630-80,000$1,302
PROMIS NEUROSCIENCES INC 1,066,674 +534,759 $1,227
     PMN1,066,674+534,759$1,227
CONTEXT THERAPEUTICS INC 725,951 UNCH $820
     CNTX725,951UNCH$820
MEDAVAIL HOLDINGS INC 117,897 +0 $529
     MDVL117,897UNCH$529
ARDELYX INC $0 (exited)
     ARDX0-881,356$0
BLACK DIAMOND THERAPEUTICS I $0 (exited)
     BDTX0-634,191$0
CYTOKINETICS INC $0 (exited)
     CYTK0-223,382$0
MIRATI THERAPEUTICS INC 0 -70,283 $0 (exited)
     MRTX0-70,283$0

See Summary: Ally Bridge Group NY LLC Top Holdings
See Details: Top 10 Stocks Held By Ally Bridge Group NY LLC

All Stocks Held By Ally Bridge Group NY LLC | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.